DB
Price
$35.30
Change
+$0.50 (+1.44%)
Updated
Sep 4, 04:18 PM (EDT)
Capitalization
67.01B
55 days until earnings call
DBD
Price
$59.55
Change
-$0.29 (-0.48%)
Updated
Sep 4, 02:24 PM (EDT)
Capitalization
2.19B
63 days until earnings call
SLN
Price
$5.25
Change
+$0.25 (+4.99%)
Updated
Sep 4, 01:10 PM (EDT)
Capitalization
226.72M
75 days until earnings call
Interact to see
Advertisement

DB or DBD or SLN

Header iconDB vs DBD vs SLN Comparison
Open Charts DB vs DBD vs SLNBanner chart's image
Deutsche Bank Aktiengesellschaft
Price$35.30
Change+$0.50 (+1.44%)
Volume$1.65K
Capitalization67.01B
Diebold Nixdorf
Price$59.55
Change-$0.29 (-0.48%)
Volume$100
Capitalization2.19B
Silence Therapeutics
Price$5.25
Change+$0.25 (+4.99%)
Volume$100
Capitalization226.72M
DB vs DBD vs SLN Comparison Chart in %
Loading...
DB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (DB: $34.81DBD: $59.84SLN: $5.03)
Brand notoriety: DBD and SLN are not notable and DB is notable
DB represents the Regional Banks industry, DBD is part of the Packaged Software industry, and SLN is in the Biotechnology industry.
Current volume relative to the 65-day Moving Average: DB: 85%, DBD: 81%, SLN: 33%
Market capitalization -- DB: $67.01B, DBD: $2.19B, SLN: $226.72M
DB [@Regional Banks] is valued at $67.01B. DBD’s [@Packaged Software] market capitalization is $2.19B. SLN [@Biotechnology] has a market capitalization of $226.72M. The market cap for tickers in the [@Regional Banks] industry ranges from $166.44B to $0. The market cap for tickers in the [@Packaged Software] industry ranges from $310.05B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Regional Banks] industry is $7.8B. The average market capitalization across the [@Packaged Software] industry is $8.95B. The average market capitalization across the [@Packaged Software] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DB’s FA Score shows that 3 FA rating(s) are green whileDBD’s FA Score has 0 green FA rating(s), and SLN’s FA Score reflects 1 green FA rating(s).

  • DB’s FA Score: 3 green, 2 red.
  • DBD’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, DB is a better buy in the long-term than DBD, which in turn is a better option than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DB’s TA Score shows that 4 TA indicator(s) are bullish while DBD’s TA Score has 5 bullish TA indicator(s), and SLN’s TA Score reflects 5 bullish TA indicator(s).

  • DB’s TA Score: 4 bullish, 4 bearish.
  • DBD’s TA Score: 5 bullish, 4 bearish.
  • SLN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DBD is a better buy in the short-term than DB, which in turn is a better option than SLN.

Price Growth

DB (@Regional Banks) experienced а -0.66% price change this week, while DBD (@Packaged Software) price change was -5.00% , and SLN (@Biotechnology) price fluctuated -3.27% for the same time period.

The average weekly price growth across all stocks in the @Regional Banks industry was +0.36%. For the same industry, the average monthly price growth was +5.21%, and the average quarterly price growth was +13.24%.

The average weekly price growth across all stocks in the @Packaged Software industry was -2.71%. For the same industry, the average monthly price growth was -1.62%, and the average quarterly price growth was +23.15%.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.69%. For the same industry, the average monthly price growth was +5.94%, and the average quarterly price growth was +27.73%.

Reported Earning Dates

DB is expected to report earnings on Oct 29, 2025.

DBD is expected to report earnings on Nov 06, 2025.

SLN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Regional Banks (+0.36% weekly)

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

@Packaged Software (-2.71% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

@Biotechnology (-0.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DB($67B) has a higher market cap than DBD($2.19B) and SLN($227M). DB YTD gains are higher at: 104.164 vs. DBD (39.033) and SLN (-26.890). SLN has less debt than DBD and DB: SLN (0) vs DBD (1.06B) and DB (132B). DB has higher revenues than DBD and SLN: DB (31B) vs DBD (3.67B) and SLN (27.2M).
DBDBDSLN
Capitalization67B2.19B227M
EBITDAN/A276M-84.82M
Gain YTD104.16439.033-26.890
P/E Ratio12.14N/AN/A
Revenue31B3.67B27.2M
Total CashN/A294M114M
Total Debt132B1.06B0
FUNDAMENTALS RATINGS
DB: Fundamental Ratings
DB
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
4
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBDBDSLN
RSI
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
55%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 9 days ago
82%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGOIX30.740.10
+0.33%
First Eagle Overseas I
PJGZX23.33N/A
N/A
PGIM Jennison Focused Value Z
FSCRX25.34N/A
N/A
Fidelity Small Cap Discovery
GSITX58.77N/A
N/A
Goldman Sachs Small Cp Val Insghts Instl
TQVIX18.80N/A
N/A
T. Rowe Price Integrated US LCV Eq I